Company Filing History:
Years Active: 2005-2008
Title: The Innovative Genius of Henry R. DuBois, III
Introduction
Henry R. DuBois, III is a notable inventor based in Catskill, NY, who has made significant contributions in the field of pharmaceutical innovations. With a total of two patents to his name, he has focused primarily on developing advanced compositions and methods aimed at treating conditions such as insomnia.
Latest Patents
DuBois's latest patents include the development of a polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide. This innovation, specifically labeled as Polymorph Form III, is designed for use as a sedative-hypnotic, anxiolytic, anticonvulsant, and/or skeletal muscle relaxant agent. The related compositions and methods disclosed in his patents highlight their application in effectively treating insomnia, showcasing his commitment to addressing pressing health concerns through innovation.
Career Highlights
Henry R. DuBois, III currently works at Neurocrine Biosciences, Inc., a company recognized for its dedication to developing novel therapies for neurological and endocrine-related disorders. His work at Neurocrine has facilitated the exploration and advancement of cutting-edge treatments, contributing to the broader mission of improving patient health and quality of life.
Collaborations
Throughout his career, DuBois has collaborated with esteemed colleagues such as Scott E. Zook and Donald Nicholas Hettinger. These partnerships have played a vital role in fostering creativity and innovation, bringing together diverse expertise to tackle complex challenges in pharmaceutical development.
Conclusion
In conclusion, Henry R. DuBois, III exemplifies the spirit of innovation within the pharmaceutical industry. His two patents demonstrate his commitment to improving therapeutic options for patients, especially those suffering from insomnia. With a solid foundation in research and collaboration at Neurocrine Biosciences, he continues to pave the way for future advancements in medicine.